Microcalcifications of breast cancer and atypical cystic lobules associated with infiltration of foam cells expressing osteopontin

Virchows Archiv

Volumn 440, Issue 3, 2002, Pages 267-273

  Oyama, Tetsunari ^a   Sano, Takaaki ^a   Hikino, Toshiaki ^a   Xue, Qi ^a   Iijima, Kotaro ^a   Nakajima, Takashi ^a   Koerner, Frederick ^b  

^a GUNMA UNIVERSITY   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atypical cystic lobules; Breast cancer; Microcalcification; Osteopontin

Indexed keywords

EOSIN; HEMATOXYLIN; HYDROXYAPATITE; MESSENGER RNA; OSTEOPONTIN;

ARTICLE; BIOMINERALIZATION; BREAST CANCER; CALCIFICATION; CANCER GRADING; CARCINOMA IN SITU; CELL INFILTRATION; COMEDO; CONTROLLED STUDY; FOAM CELL; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BREAST; BREAST NEOPLASMS; CALCINOSIS; CALCIUM; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOAM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OSTEOPONTIN; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM; SIALOGLYCOPROTEINS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 0036122534     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100501     Document Type: Article

References (39)

1. A monoclonal antibody against osteopontin inhibits RGD-mediated cell adhesion to osteopontin
2. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer
3. Osteopontin expression and distribution in human carcinomas
4. Evidence that breast cancer associated microcalcification are mineralized malignant cells
5. Mammary foam cells. Characterization by immunohistochemistry and in situ hybridization
6. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma
7. Long-term follow-up of in situ carcinoma of the breast
8. Microcalcifications in ductal carcinoma in situ of the breast: Histochemical and immunohistochemical study
9. Different types of microcalcifications observed in breast pathology. Correlations with histopathological diagnosis and radiological examination of operative specimens
10. Columnar alteration with prominent apical snouts and secretions: A spectrum of changes frequently present in breast biopsies performed for microcalcifications
11. Osteopontin: A versatile regulator of inflammation and biomineralization
12. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers
13. Calcium oxalate crystals in the breast. Pathology and significance
14. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci
15. Microcalcifications associated with ductal carcinoma in situ: Mammographic-patholoogic correlation
16. Nucleation of hydroxyapatite by bone sialoprotein
17. Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation
18. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins
19. Diagnosis of nonpalpable calcified lesions in the breast
20. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification
21. Clinico-pathological characteristics of atypical cystic duct (ACD) of the breast: Assessment of ACD as a precancerous lesion
22. Biopsy of occult breast lesions. Analysis of 1261 abnormalities
23. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): A simulator of normal mammary epithelium
24. Atypical cystic lobules: An early stage in the formation of low-grade ductal carcinoma in situ
25. Hypersecretory hyperplasia with atypia in breast biopsies, what is the proper level of clinical concern?
26. Osteopontin expression in mammary gland development and tumorigenesis
27. Epithelial hyperplasia
28. Correlation of suspicious mammograms and x-rays of breast biopsies during surgery. Results in 60 cases
29. Purification of a human milk protein closely similar to tumor-associated secreted phosphoproteins and osteopontin
30. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer
31. Identification of two phosphorylation motifs in bovine osteopontin
32. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype
33. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins
34. Atypical ductal hyperplasia, atypical lobular hyperplasia, and interpretation of a new borderline lesion
35. Osteopontin expression in a group of lymph node negative breast cancer patients
36. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin
37. Structure and function of the phosphorylated residues of casein